{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:24:58Z","timestamp":1791577498187,"version":"4.3.4"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81173002"],"award-info":[{"award-number":["81173002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science & Technology Pillar Program","award":["2012BAI35B02"],"award-info":[{"award-number":["2012BAI35B02"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.ejpb.2014.04.011","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T05:02:23Z","timestamp":1400043743000},"page":"104-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["A novel technology using transscleral ultrasound to deliver protein loaded nanoparticles"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6809-6470","authenticated-orcid":false,"given":"Di","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanbin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejpb.2014.04.011_b0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/17441692.2011.634815","article-title":"An estimation of the worldwide economic and health burden of visual impairment","volume":"7","author":"Gordois","year":"2012","journal-title":"Global Public Health"},{"issue":"7","key":"10.1016\/j.ejpb.2014.04.011_b0010","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1080\/07853890600946724","article-title":"Age-related macular degeneration-emerging pathogenetic and therapeutic concepts","volume":"38","author":"Gehrs","year":"2006","journal-title":"Ann. Med."},{"issue":"14","key":"10.1016\/j.ejpb.2014.04.011_b0015","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"New Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ejpb.2014.04.011_b0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","article-title":"Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"issue":"27","key":"10.1016\/j.ejpb.2014.04.011_b0025","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age-related macular degeneration","volume":"351","author":"Gragoudas","year":"2004","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ejpb.2014.04.011_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4419-9920-7_1","article-title":"Selection of drug delivery approaches for the back of the eye: opportunities and unmet needs","volume":"2","author":"Marsh","year":"2011","journal-title":"Drug Prod. Develop. Back Eye"},{"key":"10.1016\/j.ejpb.2014.04.011_b0035","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.preteyeres.2010.08.002","article-title":"Applications of nanoparticles in ophthalmology","volume":"29","author":"Diebold","year":"2010","journal-title":"Progr. Retinal Eye Res."},{"issue":"4","key":"10.1016\/j.ejpb.2014.04.011_b0040","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1517\/17425247.4.4.371","article-title":"Novel approaches to retinal drug delivery","volume":"4","author":"Janoria","year":"2007","journal-title":"Expert Opin. Drug Deliv."},{"issue":"5","key":"10.1016\/j.ejpb.2014.04.011_b0045","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00006982-200410000-00002","article-title":"Risks of intravitreous injection: a comprehensive review","volume":"24","author":"Jager","year":"2004","journal-title":"Retina"},{"issue":"10","key":"10.1016\/j.ejpb.2014.04.011_b0050","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1167\/iovs.08-3148","article-title":"Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits","volume":"50","author":"Nomoto","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.ejpb.2014.04.011_b0055","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0014-4835(77)90136-1","article-title":"Diffusion across the sclera","volume":"25","author":"Maurice","year":"1977","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.ejpb.2014.04.011_b0060","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0169-409X(01)00193-4","article-title":"Transscleral drug delivery for posterior segment disease","volume":"52","author":"Geroski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.ejpb.2014.04.011_b0065","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000108117","article-title":"Transport barriers in transscleral drug delivery for retinal diseases","volume":"39","author":"Kim","year":"2007","journal-title":"Ophthalmic Res."},{"issue":"6","key":"10.1016\/j.ejpb.2014.04.011_b0070","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.preteyeres.2010.04.001","article-title":"Protein delivery for retinal diseases: from basic considerations to clinical applications","volume":"29","author":"El Sanharawi","year":"2010","journal-title":"Progr. Retinal Eye Res."},{"issue":"3","key":"10.1016\/j.ejpb.2014.04.011_b0075","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2014.04.011_b0080","first-page":"437","article-title":"Microparticles and nanoparticles in ocular drug delivery","volume":"130","author":"Murali","year":"2003","journal-title":"Drugs Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ejpb.2014.04.011_b0085","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1081\/DDC-120003445","article-title":"Ocular preparations: the formulation approach","volume":"28","author":"Kaur","year":"2002","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2014.04.011_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2003.09.016","article-title":"Vesicular systems in ocular drug delivery: an overview","volume":"269","author":"Kaur","year":"2004","journal-title":"Int. J. Pharam."},{"issue":"3","key":"10.1016\/j.ejpb.2014.04.011_b0095","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1021\/mp2005164","article-title":"Hydrophilic prodrug approach for reduced pigment binding and enhanced transscleral retinal delivery of celecoxib","volume":"9","author":"Malik","year":"2012","journal-title":"Mole. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2014.04.011_b0100","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jconrel.2007.11.016","article-title":"Charged nanoparticles delivery to the eye using hydrogel iontophoresis","volume":"126","author":"Eljarrat-Binstock","year":"2008","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ejpb.2014.04.011_b0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijpharm.2010.09.001","article-title":"Ultrasound-enhanced intrascleral delivery of protein","volume":"401","author":"Cheung","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2014.04.011_b0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11095-008-9756-3","article-title":"Intrascleral drug delivery to the eye using hollow microneedles","volume":"26","author":"Jiang","year":"2009","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.ejpb.2014.04.011_b0115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0168-3659(00)00267-4","article-title":"Long-term sustained release of ganciclovir from biodegradable scleral implant for the treatment of cytomegalovirus retinitis","volume":"68","author":"Kunou","year":"2000","journal-title":"J. Controlled Release"},{"issue":"10","key":"10.1016\/j.ejpb.2014.04.011_b0120","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1167\/iovs.11-7983","article-title":"Edaravone-loaded liposome eyedrops protect against light-induced retinal damage in mice","volume":"52","author":"Shimazaki","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2014.04.011_b0125","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/jop.1994.10.509","article-title":"Pilocarpine incorporated into a submicron emulsion vehicle causes an unexpectedly prolonged ocular hypotensive effect in rabbits","volume":"10","author":"Naveh","year":"1994","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.ejpb.2014.04.011_b0130","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s11095-009-9835-0","article-title":"Human scleral diffusion of anticancer drugs from solution and nanoparticle formulation","volume":"26","author":"Kim","year":"2009","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.ejpb.2014.04.011_b0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0734-9750(02)00003-4","article-title":"Applications of natural silk protein sericin in biomaterials","volume":"20","author":"Zhang","year":"2002","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejpb.2014.04.011_b0140","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1016\/j.biomaterials.2010.02.024","article-title":"Controlling silk fibroin particle features for drug delivery","volume":"31","author":"Lammel","year":"2010","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.ejpb.2014.04.011_b0145","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/jmri.22173","article-title":"Low-intensity pulsed ultrasound increases cellular uptake of superparamagnetic iron oxide nanomaterial: results from human osteosarcoma cell line U2OS","volume":"31","author":"Wang","year":"2010","journal-title":"J. Magn. Reson. Imaging"},{"issue":"1\u20139","key":"10.1016\/j.ejpb.2014.04.011_b0150","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ultras.2003.11.013","article-title":"Radionuclide tumour therapy with ultrasound contrast microbubbles","volume":"42","author":"van Wamel","year":"2004","journal-title":"Ultrasonics"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2014.04.011_b0155","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0304-3835(99)00358-4","article-title":"Enhanced cytotoxic effect of Ara-C by low intensity ultrasound to HL-60 cells","volume":"149","author":"Tachibana","year":"2000","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.ejpb.2014.04.011_b0160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10156-004-0319-1","article-title":"Ultrasonic-enhanced gentamicin transport through colony biofilms of Pseudomonas aeruginosa and Escherichia coli","volume":"10","author":"Carmen","year":"2004","journal-title":"J. Infect. Chemother."},{"issue":"3","key":"10.1016\/j.ejpb.2014.04.011_b0165","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1023\/A:1016096626810","article-title":"Transdermal drug delivery using low-frequency sonophoresis","volume":"13","author":"Mitragotri","year":"1996","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.ejpb.2014.04.011_b0170","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejpb.2005.02.002","article-title":"Silk fibroin as a novel coating material for controlled release of theophylline","volume":"60","author":"Bayraktar","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ejpb.2014.04.011_b0175","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jconrel.2005.12.009","article-title":"Silk fibroin as an organic polymer for controlled drug delivery","volume":"111","author":"Hofmann","year":"2006","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ejpb.2014.04.011_b0180","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s11051-006-9162-x","article-title":"Formation of silk fibroin nanoparticles in water-miscible organic solvent and their characterization","volume":"9","author":"Zhang","year":"2007","journal-title":"J. Nanopart. Res."},{"issue":"18","key":"10.1016\/j.ejpb.2014.04.011_b0185","doi-asserted-by":"crossref","first-page":"10298","DOI":"10.1021\/jf202036v","article-title":"Bioconjugation of neutral protease on silk fibroin nanoparticles and application in the controllable hydrolysis of sericin","volume":"59","author":"Zhu","year":"2011","journal-title":"J. Agricult. Food Chem."},{"key":"10.1016\/j.ejpb.2014.04.011_b0190","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.2147\/IJN.S36883","article-title":"A new approach to the treatment of recurrent aphthous stomatitis with bioadhesive gels containing cyclosporine A solid lipid nanoparticles: in vivo\/in vitro examinations","volume":"7","author":"Karavana","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.ejpb.2014.04.011_b0195","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/jps.23370","article-title":"Influence of drug lipophilicity on drug release from sclera after iontophoretic delivery of mixed micellar carrier system to human sclera","volume":"102","author":"Chopra","year":"2013","journal-title":"J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2014.04.011_b0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijpharm.2009.12.046","article-title":"Iontophoretic transport of charged macromolecules across human sclera","volume":"388","author":"Chopra","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.04.011_b0205","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.actbio.2012.03.007","article-title":"Sodium dodecyl sulfate-induced rapid gelation of silk fibroin","volume":"8","author":"Wu","year":"2012","journal-title":"Acta Biomater."},{"issue":"15","key":"10.1016\/j.ejpb.2014.04.011_b0210","first-page":"670","article-title":"Ultrasound and transdermal drug delivery","volume":"9","author":"Lavon","year":"2004","journal-title":"Drug DiscoveryToday"},{"key":"10.1016\/j.ejpb.2014.04.011_b0215","unstructured":"I. Fatt, Physiology of the Eye: An Introduction to the Vegetative Functions, Butterworths London, 1978."},{"issue":"3","key":"10.1016\/j.ejpb.2014.04.011_b0220","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0168-3659(03)00151-2","article-title":"Transscleral permeability and intraocular concentrations of cisplatin from a collagen matrix","volume":"89","author":"Gilbert","year":"2003","journal-title":"J. Controlled Release"},{"issue":"2","key":"10.1016\/j.ejpb.2014.04.011_b0225","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/108076804773710830","article-title":"Scleral permeability of a small, single-stranded oligonucleotide","volume":"20","author":"Shuler","year":"2004","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2014.04.011_b0230","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-4419-9920-7_7","article-title":"Transscleral drug delivery","author":"Geroski","year":"2011","journal-title":"Drug Prod. Develop. Back Eye"},{"issue":"12","key":"10.1016\/j.ejpb.2014.04.011_b0235","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/js9802594","article-title":"Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye","volume":"87","author":"Prausnitz","year":"1998","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ejpb.2014.04.011_b0240","first-page":"1181","article-title":"Diffusion of high molecular weight compounds through sclera","volume":"41","author":"Ambati","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.ejpb.2014.04.011_b0245","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1021\/ie9800952","article-title":"Measurement and prediction of transient transport across sclera for drug delivery to the eye","volume":"37","author":"Prausnitz","year":"1998","journal-title":"Ind. Eng. Chem. Res."},{"issue":"6","key":"10.1016\/j.ejpb.2014.04.011_b0250","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1167\/iovs.13-11978","article-title":"Ultrasound-mediated transscleral delivery of macromolecules to the posterior segment of rabbit eye in vivo","volume":"54","author":"Suen","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2014.04.011_b0255","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1021\/bm0345460","article-title":"Structure and properties of silk hydrogels","volume":"5","author":"Kim","year":"2004","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2014.04.011_b0260","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijpharm.2009.12.052","article-title":"Silk fibroin nanoparticles for cellular uptake and control release","volume":"388","author":"Kundu","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.04.011_b0265","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2010.11.007","article-title":"Silk fibroin as a vehicle for drug delivery applications","volume":"150","author":"Wenk","year":"2011","journal-title":"J. Controlled Release"},{"issue":"8","key":"10.1016\/j.ejpb.2014.04.011_b0270","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.progpolymsci.2007.05.013","article-title":"Silk as a biomaterial","volume":"32","author":"Vepari","year":"2007","journal-title":"Prog. Polym. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2014.04.011_b0275","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1021\/ma00203a017","article-title":"Solvent-and mechanical-treatment-induced conformational transition of silk fibroins studies by high-resolution solid-state carbon-13 NMR spectroscopy","volume":"23","author":"Ishida","year":"1990","journal-title":"Macromolecules"},{"issue":"10","key":"10.1016\/j.ejpb.2014.04.011_b0280","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/ma00152a009","article-title":"Conformational characterization of Bombyx mori silk fibroin in the solid state by high-frequency carbon-13 cross polarization-magic angle spinning NMR, X-ray diffraction, and infrared spectroscopy","volume":"18","author":"Asakura","year":"1985","journal-title":"Macromolecules"},{"issue":"12","key":"10.1016\/j.ejpb.2014.04.011_b0285","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1211\/jpp.57.12.0005","article-title":"Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration","volume":"57","author":"Amrite","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejpb.2014.04.011_b0290","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/039139880402700112","article-title":"Adhesion and function of rat liver cells adherent to silk fibroin\/collagen blend films","volume":"27","author":"Cirillo","year":"2004","journal-title":"Int. J. Artif. Organs"},{"issue":"7\u20138","key":"10.1016\/j.ejpb.2014.04.011_b0295","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.biomaterials.2003.08.045","article-title":"Electrospinning of silk fibroin nanofibers and its effect on the adhesion and spreading of normal human keratinocytes and fibroblasts in vitro","volume":"25","author":"Min","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2014.04.011_b0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7696(03)31001-0","article-title":"Role of mucins in the function of the corneal and conjunctival epithelia","volume":"231","author":"Gipson","year":"2003","journal-title":"Int. Rev. Cytol."},{"issue":"6","key":"10.1016\/j.ejpb.2014.04.011_b0305","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1167\/iovs.10-6501","article-title":"Sonoporation enhances chemotherapeutic efficacy in retinoblastoma cells in vitro","volume":"52","author":"Lee","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2014.04.011_b0310","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/bp000024+","article-title":"Low-frequency sonophoresis: a noninvasive method of drug delivery and diagnostics","volume":"16","author":"Mitragotri","year":"2000","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.ejpb.2014.04.011_b0315","series-title":"Properties of Polymers: Their Estimation and Correctionwith Chemical Structure","author":"Van Krevelen","year":"2009"},{"key":"10.1016\/j.ejpb.2014.04.011_b0320","unstructured":"Food, U.S., D. Administration and Others, Information for manufacturers seeking marketing clearance of diagnostic ultrasound systems and transducers. Rockville, MD: Center for Devices and Radiological Health, US Food and Drug Administration, 1997."},{"issue":"6","key":"10.1016\/j.ejpb.2014.04.011_b0325","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1109\/58.808882","article-title":"Theoretical study of steady-state temperature rise within the eye due to ultrasound insonation","volume":"46","author":"Herman","year":"1999","journal-title":"Ultrason., Ferroelect. Frequency Contr., IEEE Trans."},{"issue":"10","key":"10.1016\/j.ejpb.2014.04.011_b0330","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.7863\/jum.2004.23.10.1349","article-title":"Drug delivery into the eye with the use of ultrasound","volume":"23","author":"Zderic","year":"2004","journal-title":"J. Ultrasound Med."},{"issue":"8","key":"10.1016\/j.ejpb.2014.04.011_b0335","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/01.ico.0000134189.33549.cc","article-title":"Ultrasound-enhanced transcorneal drug delivery","volume":"23","author":"Zderic","year":"2004","journal-title":"J. Cornea External Dis."},{"issue":"3","key":"10.1016\/j.ejpb.2014.04.011_b0340","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-5629(00)00204-0","article-title":"International recommendations and guidelines for the safe use of diagnostic ultrasound in medicine","volume":"26","author":"Barnett","year":"2000","journal-title":"Ultrasound Med. Biol."},{"issue":"3","key":"10.1016\/j.ejpb.2014.04.011_b0345","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0301-5629(98)00172-0","article-title":"Rationale and derivation of MI and TI \u2013 a review","volume":"25","author":"Abbott","year":"1999","journal-title":"Ultrasound Med. Biol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641114001283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641114001283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T08:41:50Z","timestamp":1565426510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641114001283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0939641114001283"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2014.04.011","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel technology using transscleral ultrasound to deliver protein loaded nanoparticles","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2014.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}